Overview
Status
Active
Registry date
2001-04-25
Share capital
321 900,00 PLN
Registered address
Wałbrzyska 13, 60-198 Poznań, Poland
Electronic delivery address
AE:PL-35458-72597-ERVFB-24
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 14.59mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 330.45kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 14.17mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 3.73mMedianUSD 539.29kAverageUSD 10.66m
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
64 1240 1747 1111 0000 1849 0271
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Katarzyna Anna Urbańska — President of the Management Board
Manner of representation
With a multi-member management board: two members of the management board, or one member of the management board jointly with a commercial proxy.
Supervisory board
Ewa Maria Trojanowska — Supervisory Board Member
Jarosław Olszewski — Supervisory Board Member
Waldemar Jarosław Szwarczyński — Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Biofarm Sp. z o.o. | 3,218 | $86,925.99 | 99.9689% |
Others | 1 | $27.01 | 0.0311% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Grażyna Małgorzata Denkowska-Szwarczyńska (75) | 36,39 % udziałów w spółce biofarm sp.z o.o., która posiada 99,97 % udziałów w spółce | |
Waldemar Jarosław Szwarczyński (73) | 45,43 % udziałów w spółce biofarm sp. z o.o. , która posiada 99,97 % udziałów w spółce |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fresenius Medical Care PolskaS.A. | $81,891,916.01 | freseniusmedicalcare.pl | ||
| Dermaticsp. z o.o. | $33,423,317.64 | dermatic.pl | ||
| EMS - Euromed Medical Solutionsp. z o.o. | $14,713,557.54 | euromed.net.pl | ||
| MedaseptS.A. | $8,612,031.18 | medasept.pl | ||
| PHS Hospitalsp. z o.o. + limited partnership | $1,933,301.24 | phs.med.pl | ||
| Medaidsp. z o.o. | $1,034,514.88 | medaid.pl | ||
| Medicallenssp. z o.o. | $179,960.83 | medicallens.com | ||
| Integris Medical Polskasp. z o.o. | $159,033.76 | integrismedical.pl | ||
| Aptekssp. z o.o. | $13,537.42 | apteks.com | ||
| HA Technologiessp. z o.o. | $206.67 | amalian.pl |
Change history
| Date | Event | |
|---|---|---|
| 2009-08-10 | Name change (Biofarm - Hurt Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji → Biofarm - Hurt) | |
| 2009-06-30 | Liquidation ended / withdrawn | |
| 2007-08-28 | Name change (Biofarm - Hurt → Biofarm - Hurt Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2007-08-01 | Liquidation opened | |
| 2001-10-04 | Share capital change (221,900.00 PLN → 321,900.00 PLN) |
FAQ
The main business activity of Biofarm - Hurt focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on April 25, 2001.
The headquarters is located at: Wałbrzyska 13, 60-198 Poznań.
The share capital of the company is PLN 321,900 (approx. $86,953).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $14,585,128, representing an increase of 52.1% compared to 2024.
Yes, the company recorded a net profit of $330,451 in 2025, meaning the company increased its profit by 138.6%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $13,467,903 in 2025, representing 95% of all operating expenses.
Last updated: 2026-08-05